it is a little bit different than the mrna covid shots from pfizer and moderna.me late, people were not as familiar with their product, struggled to take off in the same way. we know now that covid shots across the board are struggling with demand. it is something we see with pfizer and the dharna. but this is partnering with -- hopefully it will help to commercialize and get novavax's shot to a greater share of people. >> what does the future look like? it is sizable, 1.2 billion dollars. has some sticker shock. can we see more deals like this? >> it is a good question. it is interesting, what we are seeing is they are going to partner to make a covid flu combination vaccine. this is not something we are seeing with pfizer and moderna. they are trying to use the mrna technology to make covid and flu combination vaccines as well. we are seeing more momentum in this field. it will be interesting to see if we will see more partnerships like this going forward for pfizer and biontech like during the pandemic. it is interesting to see covid play such a big role in th

as we see with mrna, they are trying to encroach outside of covid.might see an update on rsp later this month -- rsv later this month. they are all going after flu. sanofi has a program as well. sanofi is trying to have as many options available to partner with their incumbent business to maintain the leadership. katie: what do you think they see in novavax necessarily? it's a relatively small company, u.s.-based. what do you make of this particular partner? emily: i think why the logic for this deal made sense for sanofi is that there are -- their flu vaccines use more traditional modality. i think as it is an unanswered question, how big are mrna vaccines going to be outside of the pandemic environment, all signs point to a big decline for covid as we see it today. i think sanofi wanted a traditional mechanism covid vaccine to partner with their traditional flu vaccine to have that as a defense against potential mrna competition. katie: i'm curious your thoughts on the price tag. $1.2 billion is not nothing but it is not enormous. usually an m&a yo

myocarditis with the mrna vaccines.and astrazeneca which are both vector, called vector vaccines. these things are real. the question is and what has never really been addressed but you and i have addressed is which is worse the virus or the gain you get from the vaccine you get against it? that depends on your risk group. it depends on what your doctor says. it depends on your prior history with vaccines. and that's what should have been front and center the whole time. with this kind of move, it doesn't inspire public confidence, bret, which is what we need. we need to be very upfront and open about side effects for vaccines and not kick it down the road for two years. >> bret: all right, dr. siegel, we will have you back and talk about some other things. we appreciate it. >> thanks, bret. >> bret: up next, the panel on president biden's israel policy as he vows to halted shipments of bombs if israel launches a major rafah offensive. first, here's what some of our fox affiliates around the country are covering tonight

the mrna vaccine instructs his cells to produce these rogue proteins.his will stimulate elliot's immune system to recognise and kill any remaining traces of cancer. how are you? elliot is the first patient in the uk to get the bowel cancer vaccine. he's had only mild side effects, but will be carefully monitored like more than 200 other participants in the international trial. i think it's really exciting. i think this is sort of a new era. the science behind this makes sense, this is one thing about this. my hope is that this will become standard of care. itjust makes sense that we can have something that can actually help in addition, to help patients reduce their risk of cancer recurrence. first one done. there is huge anticipation about the potential of personalised vaccines to treat cancer, but it all depends on the outcome of trials like elliot's, with thousands more nhs patients across england expected to be recruited to similar studies targeting lung, breast and other tumour types. fergus walsh, bbc news. people in more than 600 homes in surrey

. >> i have well documented concerns about mrna vaccines . concerns about mrna vaccines. >> but it'sncredible that whilst, you know, i'm not sure about what their impact of covid, but the fact that the world got together and came up with this technology could actually help cancer. >> i mean, i'm for all curing cancen >> i mean, i'm for all curing cancer, of course, but i think your bigger mrna fan than me. >> no, no, i'm not necessarily a fan. i'm just somebody who is fascinated by technology that could save lives elsewhere. >> bombshell news overnight donald trump found guilty, of course, of 34 charges to do with his hush money trial. we'll be getting your reaction to that and expert reaction and analysis from all the top commentators very, very shortly. but first, here's your news headlines . here's your news headlines. >> ben. thank you. the top stories this morning. donald trump was found guilty last night of falsifying records to cover up a sex scandal in a historic turn around from commander in chief to convicted criminal. no former or serving us president has ever been convict

says the risk to the public remains low, but it is stockpiling the current bird flu vaccine and a new mrnacine is now in the works. >> time now for your friday weather. a flood watch is in effect for north texas. flooded highways like this one near dallas yesterday are possible again today. the storms in texas this week prompting rescues like this one. the driver of that truck was pulled to safety near houston after the man who came to the rescue broke through the windshield. today's severe weather threat stretches from the southern border to memphis. some areas could see six inches of rain checking today's high temperatures, mostly 70s from new england to the northwest. mid 80s in the southeast up just how expensive daycare is becoming. >> also ahead, a guilty verdict in the doomsday cult murder case. what's next for chad daybell, who's convicted of killing three people, including two children, and later a win for cher in her fight against sonny bono's widow i love you. [vo]: confusion. i'll just take your arm. [vo]: pain. worry. and bravery. you got this. [vo]: all in the life... i love

the mrna vaccine instructs his cells to produce these rogue proteins.e effects but will be carefully monitored like more than 200 other participants in the international trial. i think it's really exciting. i think this is sort of a new era. the science behind this makes sense, this is one thing about this. my hope is that this will become standard of care. itjust makes sense that we can have something that can actually help in addition to help patients reduce their risk of cancer recurrence. there is huge anticipation about the potential of personalised vaccines to treat cancer, but it all depends on the outcome of trials like elliot's, with thousands more nhs patients across england expected to be recruited to similar studies targeting lung, breast and other tumour types. fergus walsh, bbc news. let's speak to our medical editor, fergus walsh. how long does it take for these trials to report? at how long does it take for these trials to report?— how long does it take for these trials to report? at least a couple of ears, trials to report? at least a c

elliot's personalised vaccine uses the same mrna technology as found in current covid jabs.entified. the vaccine instructs his cells to produce those rogue proteins. the hope is this will stimulate elliot's immune system to recognise and kill any remaining traces of cancer. how are you? elliot is the first patient in the uk to get the bowel cancer vaccine. he's had only mild side effects, but will be carefully monitored, like more than 200 other participants in the international trial. i think it's really exciting. i think this is sort of a new era. the science behind this makes sense. my hope is that this will become standard of care. itjust makes sense that we can have something that can actually help in addition, to help patients reduce their risk of cancer recurrence. first one done. there is huge optimism about the potential of personalised cancer vaccines, but it all depends on the outcome of trials like elliot's, with thousands more patients set to be recruited to studies targeting melanoma, lung and other tumour types. fergus walsh, bbc news. football — and all the h

the mrna vaccine instructs his cells to produce these rogue proteins.to recognise and kill any remaining traces of cancer. how are you? elliot is the first patient in the uk to get the bowel cancer vaccine. he's had only mild side effects but will be carefully monitored like more than 200 other participants in the international trial. i think it's really exciting. i think this is sort of a new era. the science behind this makes sense, this is one thing about this. my hope is that this will become standard of care. itjust makes sense that we can have something that can actually help in addition to help patients reduce their risk of cancer recurrence. there is huge anticipation about the potential of personalised vaccines to treat cancer, but it all depends on the outcome of trials like elliot's, with thousands more nhs patients across england expected to be recruited to similar studies targeting lung, breast and other tumour types. fergus walsh, bbc news. we will talk to fergus to get more detail about that later in the programme. let's have a look at to

elliot's personalised vaccine uses the same mrna technology as found in current covid jabs.te elliot's immune system to recognise and kill any remaining traces of cancer. how are you? elliot is the first patient in the uk to get the bowel cancer vaccine. he's had only mild side effects, but will be carefully monitored, like more than 200 other participants in the international trial. i think it's really exciting. i think this is sort of a new era. the science behind this makes sense. my hope is that this will become standard of care. itjust makes sense that we can have something that can actually help in addition, to help patients reduce their risk of cancer recurrence. first one done. there is huge optimism about the potential of personalised cancer vaccines, but it all depends on the outcome of trials like elliot's, with thousands more patients set to be recruited to studies targeting melanoma, lung and other tumour types. fergus walsh, bbc news. britain's oldest surviving second world war veteran is preparing to play his part in the 80th anniversary of the d—day landings.

government -- there was a report that the government is nearing an agreement to fund their mrna birdlu vaccine. to could come as early as next month. could total tens of millions of dollars. the stock was up in the premarket. now it is pairing those gains. you look at what is done in the last month, up something like 25% last week. some of these losses this morning could maybe be investors taking profits. katie: it will be fascinating to see how this develops. it would be a boon for modernity diversify their pipeline. we will continue to watch that one. what's going on with palantir? emily: they won a 480 million dollar contract in the u.s. army for work on an ai computer vision project known as the maven smart system. the contract is there may of 2029. it marks a change in palantir's strategy. the company had really been pivoting towards contracts with companies. their original message and kind of original plan was to work with governments. this is a move back to that. mandeep singh saying given the reliance on large contracts this will improve revenue, visibility and could drive mo

from moderna's perspective, they believe in mrna technology. their ceo calls it a platform.eve it worked in covid so it should work in these other places. they have spent heavily on r&d and now the question is can the revenue support that. katie: thank you so much. let's take a look at stocks hitting highs right now because amazon is hitting a new 52 week high. the company announcing it will launch a new online store in ireland in 25 that will offer products with local prices that don't include custom charges. you have barclays hitting highs with the ceo saying that the recent stock rally is evidence that investors support the u.k. bank's strategy to double down on its home market. we have a programming note. check out bloomberg space that will cover investments beyond earth. it is the latest editorial offering from our newsroom. that is bloomberg.com/space. coming up, the bloomberg technology summit in san francisco is next. that does it for "bloomberg markets." i am katie greifeld. this is bloomberg. >> from the heart of where innovation, money and power collide in silicon

with this deal novavax struggled to bring its protein based vaccine to the market and fell behind mrnance now sanofi will take a lead on selling that covid vaccine the key is the combinations. sanofi is the leading flu manufacturer and this gives sanofi a way to develop a competing non-mrna option. novavax sees combinations as the real opportunity for them. they're saying that flu and covid combination as well as other possible combinations, could make this a potentially multibillion dollar opportunity. carl >> angelica, pretty remarkable appreciate that, what's going on with that name. >>> still ahead, chinese ev maker zeekr goes public at the nyse current indications about $24 to mpy'after pricing at $21 and the coans cfo will join us in just a moment. switch to shopify so you can build it better, scale it faster and sell more. much more. take your business to the next stage when you switch to shopify. . ♪ >>> welcome back to "squawk on the street." i'm silvana henao with your cnbc news update. >>> the trump hush money trial back under way this morning with madelyne westerhout back o

testing vaccines, and this is ukrainian data, this is a representative office of the fizer company, the mrna, now here are the american data, this is a completely terrible ecology, the generation itself the ukrainian case, which was instilled in its mass, is doomed. experiments are going on, let’s say, in the social sphere, that’s what they say, we have a lot of territories, let there be even fewer people, you know, this is absolute stupidity, you can say it there, well, i’ll be the only owner there in the taiga, and what next , what will you do there in the taiga, if there is no normal society, this is precisely the main step towards the destruction of the population, why does the west need this, it needs land, now it’s like the western media, this is... weather analytics , that is, the west awaits megadrought for the next 50 and so on years, what does this mean? yes, this means that the economy is changing, the area that used to give a good harvest is turning into a desert or semi-desert, and there are absolutely terrible migration flows, where to put them, here it is ukraine, let's libera

i was fortunate to do three research daibes and the mrna trench, 36,000 feet, 35,000, 25,000 by the way, supported by a team of seven scientists i also had the good fortune to, spend 17 days at the international space station. extraordinary experience by the way, in the background of that was ten months of intensive training. we were private astronauts. so i think you have to look at each of them. but we will not do any of these endeavors if they're not worthwhile if we can't do them safely and successfully all right, larry, well, we'll see how this all shakes out. >> good luck, of course, on this endeavor larry connor, thanks for your time. >> thanks for having me the jury in the donald trump hush money trial has been deliberating now for just over ten hours after a busy morning of rehearing testimony and also rehearing dozens of pages of instructions from the judge. >> yeah. trump's fate is now in the jury's hands. more of our coverage after a quick break this making you uncomfortable good when you've got type two diabetes like me, you have up to four times greater risk of stroke, hea

and what happened during covid was the fast tracking of these mrna based vaccines properly tested for to really identify new ways of developing vaccines and of delivering vaccines. so in a way, it has speeded up the whole process. and this is having benefits not only vie for, for infectious disease and being able to generate vaccines more efficiently and effectively , but efficiently and effectively, but also for cancer. >> so could it be that in a few years time we all pop to the gp or the pharmacist or the hospital, get a jab and we know we're not going to have cancer? >> i think that might be the case for certain cancers. we already know that's happening, so for some cancers that we know are involved with a virus , like are involved with a virus, like the papillomavirus, for instance, and its association with cancer or cancer in women and head and neck cancer. we've already seen data recently about how that vaccine given to young girls and now young boys, is almost wiping out cervical cancer in the uk. and the idea here is, well, if we can identify at risk populations, it would be

going back several years in the face of ozempic, which is weight loss drugs, as well as new potential mrna can you put this in perspective, how volatile this has been? sam: the sector has been pretty volatile, including not -- including large pharma. if you look at share price moves after the first quarter, which my colleague john murphy and i talk about as how could the interesting as you go into it, because it is only four or five weeks after they just reported 4q. it turns out this was quite an interesting and exciting period for the large pharmas and the biotechs. we had one of the big drops friday in metro gen x, which ended up having a problem with one of its trials, but that is to be expected. these companies are highly reliant on the outcome of one drug or another. in the larger space, obesity still rules, but if you look at large pharma, the majority beat in the first quarter. and some -- most of them raised guidance, and some still have room to grow. whether that resulted in a short squeeze or not, you have been talking about that, but in reality, the sector did very exciting mov

it's been one of the big questions, the hope for the mrna vaccines.ine in the works, what more do you have to do to get it set up for the approval process to apply, are you using artificial intelligence to expedite that? stephane: if you look at cancer treatments in melanoma we have said we need to look at three things about an accelerated approval. so the data we shared on the show several times we've seen duration if you remember in december it was better than the two-year survival so the difference between people that are just getting around is getting wider. this very strong evidence the drug is working so that's number one. we need to be substantially enrolled. so we are working very actively two months earlier than planned. so when we are substantially enrolled it could be later this year and we need to file in the restriction dossier more information about the manufacturing process. it is allowed to go, that has been beat but it is working nonstop. a bit like during covid in the pandemic. so anticipate potentially sometime next year if a regula

the mrna vaccine instructs his cells to produce these rogue proteins.ing lung, breast and other tumour types. fergus walsh, bbc news. people in more than 600 homes in surrey have been warned not to drink the tap water after tests following a fuel leak. thames water said it was issuing the advice as a precaution. our reporter is at a water distribution centre in bramley. figs water distribution centre in bramley— water distribution centre in bramle. , bramley. as you can see, cars are steadily coming — bramley. as you can see, cars are steadily coming through. - bramley. as you can see, cars are steadily coming through. thames | steadily coming through. thames water employees are filling up the boots of those 600 households which have been told not to drink the water. they are filling up the boots because essentially they don't know how long this is going to go on for. some people are angry, others say they are extremely frustrated, they have been raising concerns for years about the quality of water. others tell me the stream in the centre of bramley sme